An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU. (2021). Indian Journal of Child Health, 8(12), 404-407. https://doi.org/10.32677/ijch.v8i12.3213